TMCnet News

U.S. Patents Awarded to Inventors in New Jersey (April 20)
[April 20, 2012]

U.S. Patents Awarded to Inventors in New Jersey (April 20)


(Targeted News Service Via Acquire Media NewsEdge) Targeted News Service Targeted News Service ALEXANDRIA, Va., April 20 -- The following federal patents were awarded to inventors in New Jersey.

*** PUCline Assigned Patent ALEXANDRIA, Va., April 20 -- PUCline, Venice, Calif., has been assigned a patent (8,159,085) developed by Jeffrey Fleisig, Bloomfield, N.J., for a "wall-mountable electrical power supplying device having a ring-like structure for receiving the power plugs and/or power adapters associated with a plurality of electrical appliances, and a housing containing and concealing the same during power supply operations." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A wall-mountable electrical power supplying device for supplying electrical power to a group of electrical appliances located in an environment. The wall-mountable device includes a power supply cord for plugging into a standard power receptacle by way of a supply power plug, and has a base housing portion having a bottom surface and a 3D interior volume. A power-ring subassembly is supported within the base housing portion, has a central aperture defining the boundaries of 3D interior volume, and is adapted for supporting a plurality of electrical receptacles and one or more electronic circuits, which are electrically connected to the power supply cord. A power-ring housing portion covers the power-ring subassembly and has a set of plug apertures allowing appliance power plugs associated with the electrical appliances to plug into the electrical receptacles mounted behind the plug apertures. A power cord portal allows a group of electrical power cords associated with the group of electrical appliances to enter/exit the 3D interior volume in a bundled manner. A cover housing portion is provided and adapted to cover the central aperture of the power-ring subassembly, and conceal appliance power plugs plugged into the electrical receptacles and appliance power cords associated with the electrical appliances. Also, a wall-mounting bracket, operably connectable to the base housing portion, is provided for mounting the electrical power supplying device on the wall surface in proximity to the standard wall receptacle." The patent application was filed on Sept. 25, 2009 (12/586,745). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,159,085&OS=8,159,085&RS=8,159,085 Written by Arpi Sharma; edited by Anand Kumar.



*** Goldeneye Assigned Patent ALEXANDRIA, Va., April 20 -- Goldeneye, San Diego, has been assigned a patent (8,158,983) developed by four co-inventors for semiconducting sheet. The co-inventors are Karl W. Beeson, Princeton, N.J., Scott M. Zimmerman, Basking Ridge, N.J., William R. Livesay, San Diego, and Richard L. Ross, Del Mar, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "A substrate-free semiconducting sheet has an array of semiconducting elements dispersed in a matrix material. The matrix material is bonded to the edge surfaces of the semiconducting elements and the substrate-free semiconducting sheet is substantially the same thickness as the semiconducting elements." The patent application was filed on Dec. 23, 2008 (12/317,635). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,158,983&OS=8,158,983&RS=8,158,983 Written by Arpi Sharma; edited by Anand Kumar.


*** Pioneer Assigned Patent ALEXANDRIA, Va., April 20 -- Pioneer, Moorestown, N.J., has been assigned a patent (8,158,899) developed by Nathan D. Bloch, Cherry Hill, N.J., for a waterproof operating device.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "A waterproof operating device has a pressure resistant housing including a support surface with one or more openings therethrough; a cover plate having corresponding openings therethrough; an elastic member having opposing major surfaces facing the support and cover plates with a protrusion extending from one major surface through an opening in the support surface. A button shaft extends through each pair of aligned openings into the protrusion. Each opposing major surface of the elastic member is maintained in direct continuous contact with the cover and support plates from the openings in the support and cover plates outward to beyond an area covered by the head portion of the button. The protrusion is dimensional for the selected elastic material and button dimensions to resist elongation from water pressure at greater than sixty meter depths, sufficient to actuate a switch element proximal to the distal end of the protrusion." The patent application was filed on March 4, 2010 (12/717,451). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,158,899&OS=8,158,899&RS=8,158,899 Written by Arpi Sharma; edited by Anand Kumar.

*** AT&T Intellectual Property II Assigned Patent for Method and System for Providing Broadband Access to a Data Network via Gas Pipes ALEXANDRIA, Va., April 20 -- AT&T Intellectual Property II, Atlanta, has been assigned a patent (8,159,933) developed by Paul Shala Henry, Holmdel, N.J., for a "method and system for providing broadband access to a data network via gas pipes." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method and system for providing broadband access to a data network via gas pipes is disclosed. Embodiments of the present invention utilize Orthogonal Frequency-Division Multiplexing (OFDM) or Frequency-Division Multiplexing (FDM) as a modulation technique in order to protect against the effects of dispersion in the gas pipes. An OFDM transceiver modulates a digital data stream into an OFDM signal, RF up-converts the OFDM signal, and transmits the RF up-converted OFDM modulated signal through a gas pipe." The patent application was filed on Feb. 4, 2011 (13/020,975). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,159,933&OS=8,159,933&RS=8,159,933 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** New Jersey Institute of Technology Assigned Patent ALEXANDRIA, Va., April 20 -- New Jersey Institute of Technology, Newark, N.J., has been assigned a patent (8,159,952) developed by Nirwan Ansari, Montville, N.J., and Ehsan Haghani, Kearny, N.J., for a "data packet traffic scheduling." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Techniques of scheduling data packets are disclosed. For example, such data packet scheduling techniques may be employed to schedule data packets on wired and/or wireless networks. An example embodiment includes techniques for scheduling voice-over-Internet protocol data packets transmitted between a base station and a subscriber station on a WiMAX network." The patent application was filed on Feb. 10, 2009 (12/368,516). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,159,952&OS=8,159,952&RS=8,159,952 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Amazon Technologies Assigned Patent ALEXANDRIA, Va., April 20 -- Amazon Technologies, Reno, Nev., has been assigned a patent (8,159,961) developed by Vivek Rai, Amsterdam, The Netherlands, Dan Mihai Dumitriu, Hopewell, N.J., and Swaminathan Sivasubramanian, Seattle, for a "load balancing utilizing adaptive thresholding." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method and a system for processing data requests in a client-server computing environment, such as the Web, are disclosed. A client device initially transmits a data request to a randomly selected first server device. The first server device may reject the data request if its request queue threshold is exceeded. The client device retransmits the data request, including the request queue threshold, to a randomly selected second server device. The second server device may reject the data request if the request queue threshold of the first server device is smaller than a request queue threshold of the second server device. The client device transmits the data request back to the first server device, including the request queue threshold of the second server device. The first server device processes the data request and adjusts its request queue threshold based on the request queue thresholds of the first and the second server devices." The patent application was filed on March 30, 2007 (11/694,667). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,159,961&OS=8,159,961&RS=8,159,961 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** AT&T Intellectual Property II Assigned Patent ALEXANDRIA, Va., April 20 -- AT&T Intellectual Property II, Atlanta, has been assigned a patent (8,159,958) developed by Rosario Martino Panzarella, Middlesex County, N.J., for a krone block dongle.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates generally to Krone block dongle. More particularly, the invention encompasses a method and an apparatus to monitor any media DSLAM port remotely off of a Krone block assignment." The patent application was filed on April 6, 2004 (10/818,570). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,159,958&OS=8,159,958&RS=8,159,958 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** MetaMEMS Assigned Patent ALEXANDRIA, Va., April 20 -- MetaMEMS, Murray Hill, N.J., has been assigned a patent (8,159,809) developed by Thaddeus John Gabara, Murray Hill, N.J., for a "reconfigurable system that exchanges substrates using coulomb forces to optimize a parameter." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A reconfigurable system is described that can optimize the performance of the system. Substrates can be detached, levitated, moved, dropped and reattached as desired by the use of Coulomb forces generate between Coulomb islands. Thus, a system using a first set of substrates for a given frequency range can be exchanged with a second set of substrates operable at a different frequency range by the use of Coulomb forces. Making this exchange in an RF system can improve the selectivity and decrease the power dissipation of the system. One of the exchanges can involve inductor to shift the frequency of oscillation, for example. A control unit can be used to control the movement and replacement of all substrates. The formation of minimal energy potentials of Coulomb forces are determined to move a substrate over an underlying substrate." The patent application was filed on Dec. 7, 2007 (11/952,995). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,159,809&OS=8,159,809&RS=8,159,809 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** AT&T Intellectual Property I Assigned Patent for System and Method for Presenting an Avatar ALEXANDRIA, Va., April 20 -- AT&T Intellectual Property I, Atlanta, has been assigned a patent (8,159,504) developed by five co-inventors for a "system and method for presenting an avatar." The co-inventors are E-Lee Chang, Mableton, Ga., Horst Schroeter, New Providence, N.J., Linda Roberts, Decatur, Ga., Darnell Clayton, Atlanta, and Madhur Khandelwal, Atlanta.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "A system that incorporates teachings of the present disclosure may include, for example, an avatar engine having a controller to retrieve a user profile, present a user an avatar having characteristics that correlate to the user profile, detect a change in a developmental growth of the user, adapt a portion of the characteristics of the avatar responsive to the detected change, and present the user the adapted avatar. Other embodiments are disclosed." The patent application was filed on Oct. 16, 2008 (12/253,074). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,159,504&OS=8,159,504&RS=8,159,504 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Princeton University Assigned Patent ALEXANDRIA, Va., April 20 -- Princeton University, Princeton, N.J., has been assigned a patent (8,158,677) developed by four co-inventors for a "treatment of viral infections by modulation of host cell metabolic pathways." The co-inventors are Josh Munger, Rochester, N.Y., Bryson Bennett, Metuchen, N.J., Thomas Shenk, Princeton, N.J., and Joshua Rabinowitz, Princeton, N.J.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Alterations of certain metabolite concentrations and fluxes that occur in response to viral infection are described. Host cell enzymes in the involved metabolic pathways are selected as targets for intervention; i.e., to restore metabolic flux to disadvantage viral replication, or to further derange metabolic flux resulting in "suicide" of viral-infected cells (but not uninfected cells) in order to limit viral propagation. While any of the enzymes in the relevant metabolic pathway can be selected, pivotal enzymes at key control points in these metabolic pathways are preferred as candidate antiviral drug targets. Inhibitors of these enzymes are used to reverse, or redirect, the effects of the viral infection. Drug candidates are tested for antiviral activity using screening assays in vitro and host cells, as well as in animal models. Animal models are then used to test efficacy of candidate compounds in preventing and treating viral infections. The antiviral activity of enzyme inhibitors is demonstrated." The patent application was filed on June 2, 2008 (12/156,517). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,158,677.PN.&OS=PN/8,158,677&RS=PN/8,158,677 Written by Shabnam Sheikh; edited by Jaya Anand.

*** Celgene Assigned Patent ALEXANDRIA, Va., April 20 -- Celgene, Summit, N.J., has been assigned a patent (8,158,672) developed by George W. Muller, Bridgewater, N.J., Hon-Wah Man, Princeton, N.J., and Weihong Zhang, Highland Park, N.J., for "fluoroalkoxy-substituted 1,3-dihydro-isoindolyl compounds and their pharmaceutical uses." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The invention encompasses novel compounds, pharmaceutically acceptable salts, hydrates, solvates, clathrates, enantiomers, diastereomers, racemates, or mixtures of stereoisomers thereof, pharmaceutical compositions of these compounds, and methods of using these compounds and compositions in mammals for treatment or prevention of diseases associated with PDE4." The patent application was filed on Jan. 20, 2011 (13/010,738). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,158,672.PN.&OS=PN/8,158,672&RS=PN/8,158,672 Written by Shabnam Sheikh; edited by Jaya Anand.

*** Signal Pharmaceuticals Assigned Patent ALEXANDRIA, Va., April 20 -- Signal Pharmaceuticals, San Diego, has been assigned a patent (8,158,635) developed by six co-inventors for "solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9H-purin-2-y- lamino]-cyclohexan-1-ol, compositions thereof, and uses therewith." The co-inventors are Marie G. Beauchamps, Flander, N.J., Louise Michelle Cameron, Nazareth, Pa., Robert Hilgraf, San Diego, Mohit Atul Kothare, Bridgewater, N.J., Manohar T. Saindane, Monmouth Junction, N.J., and Jean Xu, Warren, N.J.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9H-purin-2-y- lamino]-cyclohexan-1-ol, compositions comprising the solid forms, methods of making the solid forms and methods of their use for the treatment of various diseases and/or disorders are disclosed." The patent application was filed on Aug. 28, 2008 (12/200,146). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,158,635.PN.&OS=PN/8,158,635&RS=PN/8,158,635 Written by Shabnam Sheikh; edited by Jaya Anand.

*** Roche Palo Alto Assigned Patent ALEXANDRIA, Va., April 20 -- Roche Palo Alto, South San Francisco, Calif., has been assigned a patent (8,158,631) developed by seven co-inventors for heterocyclic antiviral compounds. The co-inventors are Elbert Chin, San Jose, Calif., Javier De Vicente Fidalgo, Glen Ridge, N.J., Jim Li, San Francisco, Alfred Sui-Ting Lui, Sunnyvale, Calif., Kristen Lynn McCaleb, Daly City, Calif., Ryan Craig Schoenfeld, San Jose, Calif., and Francisco Xavier Talamas, Mountain View, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Compounds having the formula I wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, and R.sup.5 are as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication. ##STR00001##." The patent application was filed on June 24, 2010 (12/822,630). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,158,631.PN.&OS=PN/8,158,631&RS=PN/8,158,631 Written by Shabnam Sheikh; edited by Jaya Anand.

*** Genentech Assigned Patent for Bicyclic Indole-pyrimidine PI3K Inhibitor Compounds ALEXANDRIA, Va., April 20 -- Genentech, South San Francisco, Calif., has been assigned a patent (8,158,625) developed by eleven co-inventors for "bicyclic indole-pyrimidine PI3K inhibitor compounds selective for P110 delta, and methods of use." The co-inventors are Georgette Castanedo, Redwood City, Calif., David Goldstein, Nutley, N.J., Rama Kondru, Nutley, N.J., Matthew Lucas, Nutley, N.J., Wylie Palmer, Nutley, N.J., Stephen Price, Harlow, United Kingdom, Brian Safina, Redwood City, Calif., Pascal Pierre Alexandre Savy, Harlow, United Kingdom, Eileen Mary Seward, Harlow, United Kingdom, Daniel P. Sutherlin, Burlingame, Calif., and Zachary K. Sweeney, Redwood City, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Formula I (Ia and Ib) compounds wherein (i) X.sup.1 is N and X.sup.2 is S, (ii) X.sup.1 is CR.sup.7 and X.sup.2 is S, (iii) X.sup.1 is N and X.sup.2 is NR.sup.2, (iv) X.sup.1 is CR.sup.7 and X.sup.2 is O, or (v) X.sup.1 is CR.sup.7 and X.sup.2 is NR.sup.2, including stereoisomers, tautomers, metabolites and pharmaceutically acceptable salts thereof, are useful for inhibiting the delta isoform of PI3K, and for treating disorders mediated by lipid kinases such as inflammation, immunological, and cancer. Methods of using compounds of Formula I for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed. ##STR00001##." The patent application was filed on May 26, 2010 (12/787,608). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,158,625.PN.&OS=PN/8,158,625&RS=PN/8,158,625 Written by Shabnam Sheikh; edited by Jaya Anand.

*** Memory Pharmaceuticals Assigned Patent ALEXANDRIA, Va., April 20 -- Memory Pharmaceuticals, Montvale, N.J., has been assigned a patent (8,158,629) developed by seven co-inventors for "indoles, 1H-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof." The co-inventors are Wenge Xie, Mahwah, N.J., Brian Herbert, Stockholm, N.J., Jianguo Ma, Montvale, N.J., Truc Minh Nguyen, Des Moines, Iowa, Richard Schumacher, Monroe, N.Y., Carla Maria Gauss, New York, and Ashok Tehim, Ridgewood, N.J.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates generally to the field of ligands for nicotinic acetylcholine receptors (nAChR), activation of nAChRs, and the treatment of disease conditions associated with defective or malfunctioning nicotinic acetylcholine receptors, especially of the brain. Further, this invention relates to novel compounds for example, indoles, 1H-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, which act as ligands for the .alpha.7 nAChR subtype, methods of preparing such compounds, compositions containing such compounds, and methods of use thereof." The patent application was filed on June 17, 2011 (13/162,786). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,158,629.PN.&OS=PN/8,158,629&RS=PN/8,158,629 Written by Shabnam Sheikh; edited by Jaya Anand.

*** Celgene Assigned Patent ALEXANDRIA, Va., April 20 -- Celgene, Summit, N.J., has been assigned a patent (8,158,653) developed by George W. Muller, Bridgewater, N.J., David I. Stirling, Branchburg, N.J., and Roger Shen-Chu Chen, Edison, N.J., for "pharmaceutical compositions of 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-amino isoindoline." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Substituted 2-(2,6-dioxopiperidin-3-yl)phthalimides and 1-oxo-2-(2,6-dioxopiperidin-3-yl)isoindolines are disclosed. The compounds are useful, for example, in reducing the levels of TNF.alpha. in a mammal." The patent application was filed on April 12, 2006 (11/401,862). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,158,653.PN.&OS=PN/8,158,653&RS=PN/8,158,653 Written by Shabnam Sheikh; edited by Jaya Anand.

*** Incyte Assigned Patent ALEXANDRIA, Va., April 20 -- Incyte, Wilmington, Del., has been assigned a patent (8,158,616) developed by James D. Rodgers, Landenberg, Pa., and Stacey Shepard, Voorhees, N.J., for "azetidine and cyclobutane derivatives as JAK inhibitors." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates to azetidine and cyclobutane derivatives, as well as their compositions, methods of use, and processes for preparation, which are JAK inhibitors useful in the treatment of JAK-associated diseases including, for example, inflammatory and autoimmune disorders, as well as cancer." The patent application was filed on March 10, 2009 (12/401,348). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,158,616.PN.&OS=PN/8,158,616&RS=PN/8,158,616 Written by Shabnam Sheikh; edited by Jaya Anand.

For more information about Targeted News Service products and services, please contact: Myron Struck, editor, Targeted News Service LLC, Springfield, Va., 703/304-1897; [email protected]; http://targetednews.com.

-1082873 (c) 2012 Targeted News Service

[ Back To TMCnet.com's Homepage ]